Accordingly, if augmentation of the cytotoxic antitumor response through attraction of cDC1 to the cancer site and prolongation of their retention there is a therapeutic goal, induction of specific chemokine secretion by tumor cells and other immune cells (CCL4, CCL5, XCL1) might be the appropriate strategy [19,20]. This evidence concerns the gene MPPE1 and neoplasm.